nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.234	0.33	CbGeAlD
Reboxetine—Diphenylpyraline—SLC6A3—Gilles de la Tourette syndrome	0.0814	0.394	CrCbGaD
Reboxetine—Benzatropine—SLC6A3—Gilles de la Tourette syndrome	0.0624	0.302	CrCbGaD
Reboxetine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.0431	0.0608	CbGeAlD
Reboxetine—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.0409	0.0576	CbGeAlD
Reboxetine—Atomoxetine—SLC6A3—Gilles de la Tourette syndrome	0.0398	0.193	CrCbGaD
Reboxetine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.0354	0.05	CbGeAlD
Reboxetine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.0341	0.0481	CbGeAlD
Reboxetine—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.0336	0.0474	CbGeAlD
Reboxetine—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.0323	0.0456	CbGeAlD
Reboxetine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.0296	0.0417	CbGeAlD
Reboxetine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.0285	0.0402	CbGeAlD
Reboxetine—HTR2C—brain—Gilles de la Tourette syndrome	0.0271	0.0382	CbGeAlD
Reboxetine—SLC6A4—brain—Gilles de la Tourette syndrome	0.0257	0.0362	CbGeAlD
Reboxetine—Atomoxetine—HTR2A—Gilles de la Tourette syndrome	0.0229	0.111	CrCbGaD
Reboxetine—SLC6A2—brain—Gilles de la Tourette syndrome	0.0226	0.0319	CbGeAlD
Reboxetine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.0165	0.0232	CbGeAlD
Reboxetine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.0162	0.0228	CbGeAlD
Reboxetine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.0158	0.0223	CbGeAlD
Reboxetine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.0156	0.022	CbGeAlD
Reboxetine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.0142	0.02	CbGeAlD
Reboxetine—CYP2D6—brain—Gilles de la Tourette syndrome	0.0124	0.0175	CbGeAlD
Reboxetine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.0116	0.0164	CbGeAlD
Reboxetine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.0112	0.0158	CbGeAlD
Reboxetine—ABCB1—brain—Gilles de la Tourette syndrome	0.0089	0.0126	CbGeAlD
Reboxetine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.00708	0.0839	CbGpPWpGaD
Reboxetine—HTR2C—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00567	0.0672	CbGpPWpGaD
Reboxetine—SLC6A4—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00543	0.0643	CbGpPWpGaD
Reboxetine—SLC6A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00491	0.0582	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00468	0.0554	CbGpPWpGaD
Reboxetine—SLC6A2—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00467	0.0553	CbGpPWpGaD
Reboxetine—HTR2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00399	0.0472	CbGpPWpGaD
Reboxetine—HTR2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00387	0.0459	CbGpPWpGaD
Reboxetine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00377	0.0447	CbGpPWpGaD
Reboxetine—HTR2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00361	0.0427	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00335	0.0397	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00325	0.0386	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00303	0.0359	CbGpPWpGaD
Reboxetine—HTR2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00253	0.0299	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00212	0.0252	CbGpPWpGaD
Reboxetine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00192	0.0228	CbGpPWpGaD
Reboxetine—SLC6A4—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00161	0.0191	CbGpPWpGaD
Reboxetine—SLC6A2—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00139	0.0164	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00136	0.0161	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00132	0.0156	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00123	0.0145	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00105	0.0125	CbGpPWpGaD
Reboxetine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000873	0.0103	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00077	0.00912	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000747	0.00885	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000696	0.00825	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000659	0.00781	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00064	0.00758	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000631	0.00747	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000596	0.00706	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000564	0.00668	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000502	0.00595	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000487	0.00577	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000487	0.00577	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000454	0.00538	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000444	0.00526	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000418	0.00495	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000318	0.00377	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000284	0.00336	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000275	0.00326	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000263	0.00312	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000258	0.00305	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000257	0.00304	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00025	0.00296	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000248	0.00294	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000233	0.00276	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000195	0.00231	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00018	0.00213	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000163	0.00193	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000162	0.00192	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000152	0.0018	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000148	0.00175	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000138	0.00163	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.64e-05	0.00114	CbGpPWpGaD
